1-Methylpiperazine → HCID 136377200, Verbindung

HRID 624546Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 624546
Cl.[NH2:2][C:3]1[C:12]2[CH:11]=[C:10]([CH3:13])[S:9][C:8]=2[NH:7][C:6]2[CH:14]=[CH:15][C:16]([C:18]#[N:19])=[CH:17][C:5]=2[N:4]=1.[CH3:20][N:21]1[CH2:26][CH2:25]N[CH2:23][CH2:22]1>CS(C)=O.C1(C)C=CC=CC=1>[CH3:13][C:10]1[S:9][C:8]2[NH:7][C:6]3[CH:14]=[CH:15][C:16]([C:18]#[N:19])=[CH:17][C:5]=3[N:4]=[C:3]([N:2]3[CH2:25][CH2:26][N:21]([CH3:20])[CH2:22][CH2:23]3)[C:12]=2[CH:11]=1

Komponenten

5

Reaktionsbedingungen

Temperatur
130 °C

Versuchsvorschrift

To a solution of 10-amino-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene-7-carbonitrile hydrochloride, prepared as described in the previous step, (0.6 g) in DMSO (6 mL) and toluene (6 mL), was added 1-methylpiperazine (4 mL). The mixture was heated in a 130° C. oil bath for 17 hours. The solution was concentrated, diluted with ethyl acetate (50 mL), washed with water (20 mL) and brine (20 mL), and then concentrated. The solid was dissolved in dichloromethane (10 mL) and treated with saturated sodium bicarbonate solution. The title compound was collected as a light yellow precipitate, washed with water and dichloromethane, dried, and used in the next step without additional purification. LC-MS: m/z 338 (M+1). 1H NMR (CD3OD, 400 MHz): δ (ppm) 7.19-7.15 (m, 2H), 6.74 (d, 1H), 6.37 (s, 1H), 3.51 (m, 4H), 2.53 (m, 4H), 2.34 (s, 3H), 2.32 (s, 3H).

Aufarbeitung

  1. concentrationThe solution was concentrated
  2. additiondiluted with ethyl acetate (50 mL)
  3. washwashed with water (20 mL) and brine (20 mL)
  4. concentrationconcentrated
  5. dissolutionThe solid was dissolved in dichloromethane (10 mL)
  6. additiontreated with saturated sodium bicarbonate solution
  7. customThe title compound was collected as a light yellow precipitate
  8. washwashed with water and dichloromethane
  9. customdried
  10. customused in the next step without additional purification

Quellen und Nachweise

ORD-Eintrag
ord-8703ad7d687d450092b3cd5af6ec396a
Quelldatensatz
uspto-grants-2016_04
Patentnummer
US09303041B2

Notizen zur Reaktion

Wird geladen…